ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah
ELEVATE 中心:降低犹他州药物使用障碍导致的孕产妇发病率
基本信息
- 批准号:10748243
- 负责人:
- 金额:$ 194.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-17 至 2030-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccidentsAccountingActive LearningAddressAdverse effectsAffectAlaska NativeAmerican IndiansCaringCessation of lifeClinicCollaborationsCommunitiesDependenceDiscipline of obstetricsDiscriminationDisparityDrug usageEducational CurriculumElementsEquityFamilyGleanGoalsHealthcareIndividualInfrastructureInpatientsInterventionInterviewLeadershipLearningLinkLocationMaternal HealthMaternal MortalityMedical Care TeamMedicineMental disordersMethodsMissionMorbidity - disease rateMothersNamesNative AmericansOutpatientsOverdosePatient-Focused OutcomesPerinatalPerinatal CarePersonsPharmaceutical PreparationsPopulationPopulations at RiskPostpartum PeriodPregnancyProviderRecoveryResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingReview CommitteeRoleRuralRural CommunityScientistSubstance Use DisorderSuicideSystemTestingTimeTrainers TrainingTrainingTribesUniversitiesUtahWorkaddictioncommunity engagementcommunity partnershipcommunity settingdisparity reductioneffectiveness/implementation trialexperiencefuture implementationhealth trainingimplementation scienceimproved outcomeinformantmaternal morbiditymembermultidisciplinarynext generationpregnancy associated deathpregnantprogramsresponserural settingscale upsimulationsubstance usesuccesstool
项目摘要
PROJECT SUMMARY ELEVATE CENTER
Accidental drug overdose and suicide were the leading causes of pregnancy-associated death in Utah from
2015-2020, accounting for nearly 40% of all pregnancy-associated deaths over that time period. At-risk
populations, including those in rural settings and those who identify as American Indian or Alaska Native are
disproportionately affected by maternal morbidity. We bring together a transdisciplinary team with expertise in
obstetrics, addiction medicine, simulation training, experiential learning, bias and disparity reduction,
community engagement and implementation science. Together, this collaborative team will establish the
ELEVATE Maternal Health Center of Excellence. ELEVATE is named to encompass our mission to Expand
our reach across Utah and the Mountain West, LEVerage existing infrastructure, And Treat pregnant and
postpartum people with substance use disorder (SUD) who experience disparities to achieve Equity.
In response to our community partners and needs of disproportionately affected populations, we propose three
projects in years 1-5, which will be scaled up and implemented statewide and disseminated nationally in years
6 and 7. Project 1 (CEREMONY) will implement a culturally appropriate and multidisciplinary perinatal care
clinic for individuals with SUD at Sacred Circle Clinic, which is a clinic serving Native mothers. Project 2
(INSPIRE) will develop, implement and test a modular learning intervention, anchored in simulation training, for
interprofessional members of the healthcare team to reduce bias related to SUD in pregnancy. A robust train-
the-trainer curriculum will allow us to implement the program across the state and reach rural communities.
Project 3 (MEMORIES) will refine and test an expanded informant interview tool to ascertain community and
systems contributions to maternal deaths, and the role of discrimination in deaths from SUD. The tool will then
be disseminated nationally to Maternal Mortality Review Committees.
Our ELEVATE Center aims are to: (1) provide integrated and efficient leadership of the three proposed
projects, maximizing coordination with community partners and incorporating research training across all
elements of the ELEVATE Center; (2) mature our existing community partnerships and statewide networks in
order to facilitate future implementation science and effectiveness trials to reduce maternal morbidity and
mortality in Utah, and (3) reduce maternal morbidity in Utah and nationally through implementation of
community-driven interventions and training of health care practitioners.
The ELEVATE Center will rigorously investigate and identify contributors to maternal morbidity and mortality
from SUD with a focus on rural and Native populations. The multipronged approach of the ELEVATE Center
will reduce maternal morbidity from substance use in Utah while training the next generation of scientists
focused on morbidity reduction. Our efforts can ultimately be expanded nationally to address a leading cause
of pregnancy-associated death in the U.S.
项目概要 电梯中心
意外药物过量和自杀是犹他州妊娠相关死亡的主要原因
2015-2020 年,占该时期所有妊娠相关死亡的近 40%。有风险
人口,包括农村地区的人口以及美洲印第安人或阿拉斯加原住民的人口
受孕产妇发病率的影响尤为严重。我们汇集了一支跨学科团队,拥有以下领域的专业知识
产科、成瘾医学、模拟训练、体验式学习、减少偏见和差异、
社区参与和实施科学。该协作团队将共同建立
提升卓越孕产妇保健中心。 ELEVATE 的命名体现了我们扩展业务的使命
我们的业务遍及犹他州和西部山区,利用现有基础设施,并治疗怀孕和
患有物质使用障碍 (SUD) 的产后人士在实现公平方面经历了差异。
为了满足我们的社区合作伙伴和不成比例受影响人群的需求,我们提出了三项建议
第 1-5 年的项目将在全州范围内扩大和实施,并在几年内在全国范围内传播
6 和 7. 项目 1(仪式)将实施适合文化的多学科围产期护理
圣环诊所 (Sacred Circle Clinic) 为 SUD 患者提供诊所,这是一家为土著母亲提供服务的诊所。项目2
(INSPIRE) 将开发、实施和测试以模拟培训为基础的模块化学习干预措施,以
医疗团队的跨专业成员,以减少与妊娠期 SUD 相关的偏见。坚固的列车——
培训师课程将使我们能够在全州实施该计划并覆盖农村社区。
项目 3(MEMORIES)将完善和测试扩展的线人访谈工具,以确定社区和
系统对孕产妇死亡的贡献,以及歧视在 SUD 死亡中的作用。然后该工具将
向全国孕产妇死亡率审查委员会传播。
我们的 ELEVATE 中心的目标是:(1) 为拟议的三个项目提供综合、高效的领导
项目,最大限度地与社区合作伙伴协调,并将研究培训纳入所有领域
ELEVATE 中心的元素; (2) 成熟我们现有的社区合作伙伴关系和全州网络
为了促进未来实施科学和有效性试验,以降低孕产妇发病率和
犹他州的死亡率,以及 (3) 通过实施以下措施降低犹他州和全国的孕产妇发病率
社区驱动的干预措施和对卫生保健从业人员的培训。
ELEVATE 中心将严格调查并确定导致孕产妇发病和死亡的因素
来自 SUD,重点关注农村和原住民人口。 ELEVATE 中心的多管齐下方法
将减少犹他州因药物使用而导致的孕产妇发病率,同时培训下一代科学家
重点是减少发病率。我们的努力最终可以扩展到全国范围,以解决一个主要原因
美国与妊娠相关的死亡人数
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Torri D Metz其他文献
Torri D Metz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Torri D Metz', 18)}}的其他基金
Maternal Marijuana Use and Adverse Perinatal Outcomes
母亲吸食大麻和围产期不良后果
- 批准号:
10268211 - 财政年份:2020
- 资助金额:
$ 194.97万 - 项目类别:
Maternal Marijuana Use and Adverse Perinatal Outcomes
母亲吸食大麻和围产期不良后果
- 批准号:
10659144 - 财政年份:2020
- 资助金额:
$ 194.97万 - 项目类别:
Maternal Marijuana Use and Adverse Perinatal Outcomes
母亲吸食大麻和围产期不良后果
- 批准号:
10442545 - 财政年份:2020
- 资助金额:
$ 194.97万 - 项目类别:
UofU Maternal-Fetal Medicine Units (MFMU) Network: Clinical Centers
UofU 母胎医学中心 (MFMU) 网络:临床中心
- 批准号:
10680706 - 财政年份:1996
- 资助金额:
$ 194.97万 - 项目类别:
相似国自然基金
套期会计有效性的研究:实证检验及影响机制
- 批准号:72302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 194.97万 - 项目类别:
A novel driving coach app for older adults with cognitive impairment
一款针对有认知障碍的老年人的新型驾驶教练应用程序
- 批准号:
10759329 - 财政年份:2023
- 资助金额:
$ 194.97万 - 项目类别:
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.
唐氏综合症患者脑血管疾病的无创生物识别筛查。
- 批准号:
10816240 - 财政年份:2023
- 资助金额:
$ 194.97万 - 项目类别:
An active learning framework for adaptive autism healthcare
适应性自闭症医疗保健的主动学习框架
- 批准号:
10716509 - 财政年份:2023
- 资助金额:
$ 194.97万 - 项目类别:
Expanding the Catalytic Repertoire of Heme-based Dioxygenases
扩展血红素双加氧酶的催化能力
- 批准号:
10719622 - 财政年份:2023
- 资助金额:
$ 194.97万 - 项目类别: